Gefticip 250 Mg
- Manufacturer : Cipla Ltd
- Equivalent Brands : Iressa
- Generic Brands : Gefitinib
Gefticip 250mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.
Gefticip 250mg Tablets is mostly used to treat lung disease and it works by abating or halting the development of malignancy cells. Gefticip is an oncology medicate called a tyrosine kinase inhibitor (TKI), otherwise called a malignancy development inhibitor. Gefticip envision (restrains) the protein from sending signs to the disease cells that make them develop and partition.
Gefitinib is a type of biological therapy called a protein tyrosine kinase inhibitor (TKI). Tyrosine kinase is a protein which acts as a chemical messenger (an enzyme). There are a number of different tyrosine kinases that encourage cancer cells to grow.
Gefticip (Gefitinib) works by preventing lung cancer cells from growing and multiplying. Many cells, including cancer cells, have receptors on their surfaces for epidermal growth factor (EGF), a protein that is normally produced by the body and that promotes the growth and multiplication of cells. When EGF attaches to epidermal growth factor receptors (EGFRs), it causes an enzyme called tyrosine kinase to become active within the cells. Tyrosine kinase triggers chemical processes that cause the cells, including cancer cells, to grow, multiply, and spread. Gefitinib attaches to EGFRs and thereby blocks the attachment of EGF and the activation of tyrosine kinase.
Take Gefticip 250mg Tablet as instructed by the doctor. Do not consume larger quantities than prescribed. It should be used as prescribed by the doctor to prevent the spread of cancer to other parts of the body. Discontinue the treatment if any symptoms of allergic skin reactions appear.
Pregnancy - This medicine is not recommended for use in pregnant women.
Breast-feeding - This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If this medicine is prescribed, your doctor will advise you to discontinue breastfeeding.
Skin reactions - Patients receiving Gefticip 250mg Tablet have experienced severe skin reactions like toxic epidermal necrolysis, Stevens Johnson syndrome, and erythema multiforme. Close monitoring of symptoms like change in color of the skin, skin rashes, itching, blistering, etc. is necessary while receiving this medicine. Any such symptoms should be reported to the doctor on priority. The treatment should be discontinued if these symptoms appear.
If you have an allergy to gefitinib or any other part of this drug. Tell your doctor if you are allergic to any drugs. Make sure to tell about the allergy and what signs you had. This includes telling about rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you are pregnant or may be pregnant. If you are breast-feeding.
The suggested daily dose if you are going to Gefticip is one 250 mg pill with or while not food. Higher doses don’t provides a higher response and cause enhanced toxicity. However, your specialist might build dose adjustment as per needed. Gefticip through geftina t dropshipper and Gefticip wholesale Organisation. The suggested day by day measurements is one 250 mg. You ought to counsel with your specialist and take after the guideline that endorsed by specialist. Take a missed measurements when you consider it. In the event that it is near the ideal opportunity for your next dosage, avoid the missed measurement and backpedal to your typical time. Try not to take 2 measurements in the meantime or additional dosages.
Gefticip 250mg is used to treat some people with non-small cell lung cancer (NSCLC). It only works for cancers that have an abnormal form of a protein called epidermal growth factor receptor (EGFR). Tests are done on the cancer cells from a lung biopsy or previous surgery to check the level of EGFR.
Gefticip is utilized to treat a few people with non-little cell lung disease (NSCLC). It works for malignancies that have a strange type of a protein called epidermal development calculate receptor (EGFR). Tests are done on the disease cells from a lung biopsy or past surgery to check the level of EGFR.